(NASDAQ: CELC) Celcuity's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.77%.
Celcuity's revenue in 2023 is $0.On average, 1 Wall Street analysts forecast CELC's revenue for 2025 to be $504,142,089, with the lowest CELC revenue forecast at $504,142,089, and the highest CELC revenue forecast at $504,142,089. On average, 1 Wall Street analysts forecast CELC's revenue for 2026 to be $175,622,635, with the lowest CELC revenue forecast at $175,622,635, and the highest CELC revenue forecast at $175,622,635.
In 2027, CELC is forecast to generate $3,696,732,790 in revenue, with the lowest revenue forecast at $3,696,732,790 and the highest revenue forecast at $3,696,732,790.